Structural determinants of aromatase cytochrome p450 inhibition in substrate recognition site-1

Molecular Endocrinology

Volumn 16, Issue 7, 2002, Pages 1456-1468

  Conley, Alan ^a,c   Mapes, Samantha ^a   Jo Corbin, C ^b   Greger, Douglas ^c   Graham, Sandra ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; AROMATASE; CYTOCHROME P450; ETOMIDATE; IMIDAZOLE; ISOENZYME; PLACENTA ENZYME; STEROID; AROMATASE INHIBITOR; RECOMBINANT PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BETA SHEET; BINDING AFFINITY; CHIMERA; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME KINETICS; ENZYME STRUCTURE; ENZYME SUBSTRATE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CHEMISTRY; ENZYMOLOGY; FEMALE; GENETICS; GONAD; IC 50; METABOLISM; MOLECULAR GENETICS; PLACENTA; PREGNANCY; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; SWINE;

INSECTA; SUIDAE;

AMINO ACID SEQUENCE; ANIMALS; AROMATASE; AROMATASE INHIBITORS; CELLS, CULTURED; ETOMIDATE; FEMALE; GONADS; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PLACENTA; PREGNANCY; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE;

EID: 85047685695     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.7.0876     Document Type: Article

References (71)

1. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
2. Mammalian aromatases
3. Genetic mutations resulting in loss of aromatase activity in humans and mice
4. Endocrine disorders associated with inappropriately high aromatase expression
5. Breast cancer and the expression of aromatase in breast adipose tissue
6. Use of aromatase inhibitors in breast carcinoma
7. Biology of aromatase inhibitors: Pharmacology/endocrinology within the breast
8. Comprehensive pharmacology and clinical efficacy of aromatase inhibitors
9. Aromatase inhibitors: Past, present and future
10. The potential of aromatase inhibitors in breast cancer prevention
11. Estrogen biosynthesis in endometriosis: Molecular basis and clinical relevance
12. Molecular basis for treating endometriosis with aromatase inhibitors
13. Recent advances in the clinical application of aromatase inhibitors
14. Aromatase and gynecomastia
15. Use of aromatase inhibitors in precocious puberty
16. Risks versus benefits in the clinical application of aromatase inhibitors
17. Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase
18. Structural basis of selective cytochrome P450 inhibition
19. How similar are P450s and what can their differences teach us?
20. Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis
21. Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis
22. A three-dimensional model of aromatase cytochrome P450
23. Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis
24. A site-directed mutagenesis study of human placental aromatase
25. Structure-function studies of human aromatase
26. 309Ala and their interactions with aromatase inhibitors
27. Binding characteristics of seven inhibitors of human aromatase: A site-directed mutagenesis study
28. Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450
29. Diverse function of aromatase and the N-terminal sequence deleted form
30. 102-aromatase)
31. Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species
32. A comparative approach to structure-function studies of mammalian aromatases
33. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences
34. Use of chimeric enzymes and site-directed mutagenesis for identification of three key residues responsible for differences in steroid hydroxylation between canine cytochromes P-450 3A12 and 3A26
35. Identification of selective mechanism-based inactivators of cytochromes P-450 2B4 and 2B5, and determination of the molecular basis for differential susceptibility
36. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties
37. Elucidation of distinct ligand binding sites for cytochrome P450 3A4
38. Structure-function analysis of human cytochrome P450 3A4 using 7-alkoxycoumarins as active-site probes
39. The importance of SRS-1 residues in catalytic specificity of human cytochrome P450 3A4
40. Nonsubstrate recognition site residues are involved in testosterone hydroxylation by cytochrome P450 CYP 2C11
41. Structural determinants of progesterone hydroxylation by cytochrome P450 2B5: The role of nonsubstrate recognition site residues
42. Functional ovarian and placental isoforms of porcine aromatase
43. Changes in testosterone metabolism associated with the evolution of placental and gonadal isozymes of porcine aromatase cytochrome P450
44. Porcine aromatases: Studies on tissue-specific, functionally distinct isozymes from a single gene?
45. Closely related genes encode developmental and tissue isoforms of porcine cytochrome P450 aromatase
46. Multiple isoforms of porcine aromatase are encoded by three distinct genes
47. A developmental switch in expression from blastocyst to endometrial/placental-type cytochrome P450 aromatase genes in the pig and horse
48. Molecular cloning of cytochrome P450 aromatase complementary deoxyribonucleic acid from periimplantation porcine and equine blastocysts identifies multiple novel 5′-untranslated exons expressed in embryos, endometrium, and placenta
49. Functional aromatase expression in porcine adrenal gland and testis
50. Imidazole antimycotics: Selective inhibitors of steroid aromatization and progesterone hydroxylation
51. Mechanism of inhibition of microsomal drug metabolism by imidazole
52. Imidazole antimycotics: Inhibitors of steroid aromatase
53. Aromatase inhibition by flavonoids
54. Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids
55. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study
56. Engineering of cytochrome P450 2B1 specificity. Conversion of an androgen 16β-hydroxylase to a 15α-hydroxylase
57. Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles
58. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4
59. Evolution of the cytochrome P450 genes
60. Mapping determinants of the substrate selectivities of P450 enzymes by site-directed mutagenesis
61. Structural flexibility and functional versatility of cytochrome P450 and rapid evolution
62. Structural flexibility and functional versatility of mammalian P450 enzymes
63. Reciprocal size-effect relationship of the key residues in determining regio- and stereospecificities of DHEA hydroxylase activity in P450 2a5
64. Sequence requirements for cytochrome P-450IIB1 catalytic activity
65. An inhibitory monoclonal antibody binds in close proximity to a determinant for substrate binding in cytochrome P450IIC5
66. Mammalian microsomal cytochrome P450 monooxygenase: Structural adaptations for membrane binding and functional diversity
67. Microsomal cytochrome P450 2C5: Comparison to microbial P450s and unique features
68. Expression of a recombinant derivative of human aromatase P450 in insect cells utilizing the baculovirus vector system
69. Human aromatase in high yield and purity by perfusion chromatography and its characterization by difference spectroscopy and mass spectrometry
70. Purification of human placental aromatase cytochrome P-450 with monoclonal antibody and its characterization
71. Porcine gonadal and placental isozymes of aromatase cytochrome P450: Sub-cellular distribution and support by NADPH-cytochrome P450 reductase